Eisai receives FDA approval for antiepileptic drug

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...

October 1, 2018 | Monday | News
Atox Bio announces completion of pre-planned safety review

Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...

September 25, 2018 | Tuesday | News
Immutep collaborates with Merck, Pfizer for Efti

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...

September 25, 2018 | Tuesday | News
Proxima Clinical Research appoints David Novotny as CSO

David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinica...

September 24, 2018 | Monday | News
“The role of laboratories will be central to the delivery of high quality healthcare”: Jozika Habijanic

Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...

September 20, 2018 | Thursday | Opinion
Innovent presents clinical data of Sintilimab

Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...

September 20, 2018 | Thursday | News
CISCRP releases a video to improve diversity in clinical research

The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...

September 19, 2018 | Wednesday | News
Daily intake of Aspirin has little effect on cardiovascular disease, says a study

Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...

September 17, 2018 | Monday | News
Medtronic starts Onyx ONE Clear study in Japan and US

Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...

September 14, 2018 | Friday | News
Oryzon gets approval for conducting Phase IIa trial of Vafidemstat

Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...

September 10, 2018 | Monday | News
TB Alliance Launches Clinical Trial for New TB drug

TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...

August 31, 2018 | Friday | News
NUS researchers uncover a bidirectional regulator in cancer cells

Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...

August 20, 2018 | Monday | News
Tolero Pharmaceuticals collaborates with AbbVie for AML trial

Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...

August 20, 2018 | Monday | News
HSA approves TCR immunotherapy trial for liver cancer

Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...

August 20, 2018 | Monday | News
FSD Pharma, SciCann Launch clinical research program in Israel

FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...

August 17, 2018 | Friday | News
Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...

August 13, 2018 | Monday | News
Ascletis’ Ganovo achieves top clinical research award

Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...

August 1, 2018 | Wednesday | News
Immunomedics announces multiple collaborations with cancer research institutions

 Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...

July 30, 2018 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls